{"text": "$ABBV UBS Downgrades AbbVie To Neutral From Buy, Raises PT To $147 From $129 https://t.co/xKruSlBFiq", "id": "1498273700788932611", "author_id": "4058194633", "created_at": "2022-02-28T12:27:41.000Z"}
{"text": "RT @Dividend_Dollar: \ud83d\udcb5 Dividend Growth Stocks never get old\n\n5-Yr Dividend Growth Rate\n$ABBV 17.7%\n$AVGO 42.7%\n$HD 19.1%\n$LOW 17.7%\n$BAC 25\u2026", "id": "1498320096460161030", "author_id": "1152234528", "created_at": "2022-02-28T15:32:03.000Z"}
{"text": "RT @cap_ebc: $SFLM\n\n$CRM $ETSY $SQ $HTZ $FUN $SWCH $LIN $BHP $BNTX $SE $ABBV $SCCO $GSTX", "id": "1498317236079312897", "author_id": "1430800842257408003", "created_at": "2022-02-28T15:20:41.000Z"}
{"text": "$ABBV - AbbVie Seeks New Indication for IMBRUVICA\u00ae (ibrutinib) in Pediatric Patients with Chronic Graft Versus Host Disease (cGVHD)", "id": "1498282111052414980", "author_id": "1328777031299960833", "created_at": "2022-02-28T13:01:06.000Z"}
{"created_at": "2022-02-28T21:16:14.000Z", "text": "$ABBV: AbbVie Provides Update Regarding SKYRIZI\u00ae (risankizumab-rzaa) for the Treatment of Moderate to Severe Crohn's Disease in the U.S.", "id": "1498406712671363076", "author_id": "2196092280"}
